At last, we used χ2 or Fisher’s exact test to explore the relationship between GRK5/ACTC1 co-expression and the clinicopathological parameters of EOC, and we found that there were significant differences in the following factors: histology, FIGO stage, lymph node metastasis, intraperitoneal metastasis, intestinal metastasis, vital status, differentiation grade, ascites with tumor cells, and so on (Table 2). Here, GRK5 is linked to neoplasm.